Literature DB >> 21309614

Including indirect medical care costs from survivor years of life in economic evaluations.

John A Nyman1, Hawre J Jalal.   

Abstract

Mesh：

Year:  2011        PMID： 21309614     DOI： 10.2165/11588790-000000000-00000

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  3 in total

1.  Should the consumption of survivors be included as a cost in cost-utility analysis?

Authors:  John A Nyman
Journal:  Health Econ       Date:  2004-05       Impact factor: 3.046

2.  Standardizing the inclusion of indirect medical costs in economic evaluations.

Authors:  Pieter H M van Baal; Albert Wong; Laurentius C J Slobbe; Johan J Polder; Werner B F Brouwer; G Ardine de Wit
Journal:  Pharmacoeconomics       Date:  2011-03       Impact factor: 4.981

3.  Measurement of QALYS and the welfare implications of survivor consumption and leisure forgone.

Authors:  John A Nyman
Journal:  Health Econ       Date:  2009-11-27       Impact factor: 3.046
  3 in total
  1 in total

1.  PAID 1.0 in practice: a brief clarification regarding its possibilities and limitations.

Authors:  Pieter van Baal; Werner Brouwer
Journal:  Pharmacoeconomics       Date:  2011-06       Impact factor: 4.981
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.